Evidence map›Paper›PMID 32100577›Full record

ReviewExpert opinion on drug discovery2020

Discovery of drugs that directly target the intrinsically disordered region of the androgen receptor.

Marianne D Sadar

Open access · greenAbstract readReview
In one paragraph

Review in Expert opinion on drug discovery, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
5.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 78 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Ensemble Docking for Intrinsically Disordered Proteins.Journal of chemical information and modeling · 2025
    Article
  8. Article
  9. Review
  10. Ensemble docking for intrinsically disordered proteins.bioRxiv : the preprint server for biology · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Marianne D SadarGenome Sciences, BC Cancer and Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada.ORCID 0000-0003-0599-9215
University of British Columbia · CA

Funding

Novel compounds that inhibit transactivation of N-terminal domain of the androgenR01CA105304 · NCI · PROVINCIAL HEALTH SERVICES AUTHORITY · PI SADAR, MARIANNE D · 2004 to 2021
$3.7M
NCI NIH HHS R01 CA105304
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Androgen Receptor AntagonistsAnimalsDrug DiscoveryHumansIntrinsically Disordered ProteinsMaleMolecular Targeted TherapyProstatic NeoplasmsProtein FoldingReceptors, AndrogenTranscriptional ActivationAndrogen Receptor AntagonistsAR protein, humanIntrinsically Disordered ProteinsReceptors, AndrogenAndrogen receptorclinical trialdrug discoveryEPI-002intrinsically disordered proteinmechanism of actionN-terminal domain inhibitorprostate cancerralanitensintokamides

Identifiers

PMID32100577
PMCPMC8693730
OpenAlexW3008295930

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.